HRT Navigator

NICE NG23 (April 2026) · BMS 2024/2026 · RCOG · FSRH/CoSRH · Guideline reference only
SynaptAI CDMtools · © 2026

1Safety screening

ContraindicationsHRT not advised while present0 ticked
✓
Active / recent breast cancer
✓
Undiagnosed vaginal bleeding
✓
Active severe liver disease
✓
Active / recent VTE
✓
Known thrombophilia
✓
Active endometrial cancer
✓
Pregnancy
✓
Uncontrolled hypertension
CautionsHRT possible: adjust route or seek specialist input0 ticked
✓
Personal history of breast cancer
Relative contraindication — specialist input
✓
Previous VTE
Transdermal strongly preferred
✓
BMI >30
Transdermal preferred
✓
Migraine with aura
Transdermal strongly preferred
✓
Cardiovascular disease
Not a contraindication — transdermal preferred
✓
Stroke / TIA history
Transdermal strongly preferred
✓
Uterine fibroids
✓
History of endometriosis

2Clinical context

3Symptoms present

✓
Vasomotor — hot flushes, night sweats
✓
Mood / anxiety / brain fog
✓
Genitourinary — dryness, dyspareunia, UTIs
✓
Low libido / fatigue
See Testosterone tab for TRT guidance
✓
Sleep disturbance
✓
Joint / muscle pain

4Oestrogen

ScreeningNo contraindicationsNo cautions
Guideline reference only. NICE NG23 · BMS 2024/2026 · RCOG. All decisions remain with the responsible clinician. © 2026 SynaptAI Limited.
⚕

Complete the assessment above and press
Generate Guideline Reference
to produce a tailored HRT guideline summary.

★ ★ ★ ★ ★
Select a star rating above to submit
✓ Thanks — feedback received